Publicaciones en las que colabora con Renée Ribacoba Montero (20)

2014

  1. Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms

    Neuroscience Letters, Vol. 562, pp. 45-49

  2. MiRNA Profile in the Substantia Nigra of Parkinson’s Disease and Healthy Subjects

    Journal of Molecular Neuroscience, Vol. 54, Núm. 4, pp. 830-836

  3. The screening of the 3′UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson's disease

    Journal of Human Genetics, Vol. 59, Núm. 6, pp. 346-348

2013

  1. Mutational screening of PARKIN identified a 3′ UTR variant (rs62637702) associated with parkinson's disease

    Journal of Molecular Neuroscience, Vol. 50, Núm. 2, pp. 264-269

  2. Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls

    Journal of Neurology

2012

  1. A search for SNCA 3′ UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease

    Journal of Molecular Neuroscience, Vol. 47, Núm. 3, pp. 425-430

2011

  1. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease

    Movement Disorders, Vol. 26, Núm. 5, pp. 819-823

2010

  1. Analysis of the micro-RNA-133 and PITX3 genes in Parkinson's disease

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 153, Núm. 6, pp. 1234-1239

  2. FGF20 rs12720208 SNP and microRNA-433 variation: No association with Parkinson's disease in Spanish patients

    Neuroscience Letters, Vol. 479, Núm. 1, pp. 22-25

  3. Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia

    BMC Neurology, Vol. 10

2009

  1. Mutational screening of the Mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 15, Núm. 6, pp. 468-470

  2. Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease

    Journal of Neural Transmission, Vol. 116, Núm. 10, pp. 1289-1293

2008

  1. Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease

    Neuroscience Letters, Vol. 432, Núm. 1, pp. 79-82

2007

  1. No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes

    Neuroscience Letters, Vol. 413, Núm. 3, pp. 202-205

2005

  1. Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population

    Journal of the Neurological Sciences, Vol. 236, Núm. 1-2, pp. 49-54

2004

  1. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease

    Neuroscience Letters, Vol. 370, Núm. 2-3, pp. 151-154

2002

  1. Single-nucleotide polymorphisms in the promoter region of the PARKIN gene and Parkinson's disease

    Neuroscience Letters, Vol. 329, Núm. 2, pp. 149-152

1999

  1. Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease

    Journal of Neurology Neurosurgery and Psychiatry, Vol. 67, Núm. 6, pp. 733-736

  2. Association between an α2 macroglobulin DNA polymorphism and late-onset Alzheimer's disease

    Biochemical and Biophysical Research Communications, Vol. 264, Núm. 1, pp. 48-50

  3. Frecuencia del alelo APOE-4 en la enfermedad de Alzheimer en la población asturiana y su variación con la edad

    Medicina Clinica, Vol. 113, Núm. 12, pp. 441-443